Upper GI Cancer Research Review, Issue 13
In this issue:
First-line cadonilimab + chemotherapy in HER2- advanced gastric/GOJ adenocarcinoma
CheckMate 9DW: first-line nivolumab + ipilimumab vs. lenvatinib/sorafenib for unresectable HCC
GASTO 1071: neoadjuvant toripalimab + chemotherapy followed by chemo-radiotherapy for locally advanced oesophageal SCC
Neoadjuvant chemo-radiotherapy vs. chemo-immunotherapy for locally advanced oesophageal SCC
NOTCH1 as a potential predictive biomarker for OS with tislelizumab in advanced/metastatic oesophageal SCC
Claudin 18.2 (CLDN18) expression in BTCs
Hot beverage intake & oesophageal SCC
Prognostic value of preoperative ctDNA in oesophageal SCC
Expert contributor
Dr Pei Ding
Dr Pei Ding is a medical oncologist and trialist at Westmead Hospital Crown Princess Mary Cancer Centre and Nepean Hospital Cancer and Wellness Centre, with clinical expertise in managing lung and gastrointestinal cancers. She completed her fellowship and PhD study in lung cancer liquid biopsy research at the Ingham Institute of Applied Medical Research and […]
Latest Publications and Videos
Stay up to date with our latest clinical information.
Explore Research Review Publications and Videos
Dive into our publications and videos content from over 50 areas of medicine including Cardiology, Diabetes, Oncology, Haematology and Psychiatry.
Terms and Conditions
Website terms of use
By using our website, you agree to follow these terms and conditions.
Privacy policy
We take your privacy seriously. To understand how we collect, use, and protect your information, please read our Privacy Policy, which is part of these terms.
Copyright and use of website content
The content of our website is protected by copyright, trademarks, and other legal rights. You can: view, download, or print a single copy of content for your personal or professional use.
You cannot: copy, modify, or distribute website content, or use our website content for commercial purposes or in other works without permission.
Links to third-party websites
The Research Review website may link to third-party websites for your convenience. However:
We do not endorse or approve their products, services, or actions.
We are not responsible for their content or how they operate.
There is no formal partnership between us and third parties unless we clearly state otherwise.
Disclaimer and limitation of liability
We do our best to keep the information on our website accurate, but we do not guarantee that it is always correct or up to date.
To the fullest extent allowed by law, we are not responsible for:
Any loss, damage, or costs you may suffer from using (or being unable to use) our website.
Any decisions you make based on the information provided.
Any business losses, such as lost profits, lost data, or business interruptions.
Governing law
These terms are governed by New Zealand law. If there is a dispute, it must be resolved in a New Zealand court.